Seretide was GSK’s flagship treatment for asthma and COPD, that was so established and well known that there was nothing especially new to say.
We were challenged to create a dual-indication, global campaign that inspired ongoing confidence in Seretide by simply acting like a market leader and reminding HCPs what they loved about this transformational treatment.